Pharmacokinetics, Glucodynamics, Safety, and Tolerability of LY900014 in Patients With Type 2 Diabetes Mellitus on Multiple Daily Insulin Injection Therapy
Phase of Trial: Phase I
Latest Information Update: 13 Jun 2017
At a glance
- Drugs Insulin lispro (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Eli Lilly
- 13 Jun 2017 Results of first part, presented at the 77th Annual Scientific Sessions of the American Diabetes Association
- 26 Aug 2016 Status changed from active, no longer recruiting to completed.
- 15 Jul 2016 Status changed from recruiting to active, no longer recruiting.